Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03

PURPOSE: To validate lysyl oxidase (LOX), a hypoxia-related protein, as a marker for metastasis in an independent head and neck cancer (HNC) patient group enrolled onto a prospective trial. PATIENTS AND METHODS: We performed traditional immunohistochemical (IHC) staining and automated quantitative a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Le, Quynh-Thu, Harris, Jonathan, Magliocco, Anthony M., Kong, Christina S., Diaz, Roman, Shin, Brian, Cao, Hongbin, Trotti, Andy, Erler, Janine T., Chung, Christine H., Dicker, Adam, Pajak, Thomas F., Giaccia, Amato J., Ang, K. Kian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2009
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744270/
https://ncbi.nlm.nih.gov/pubmed/19667273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.6003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak